Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
jeremy_grimshaw [2022/05/09 08:17] liam | jeremy_grimshaw [2022/05/09 08:23] (current) liam [Antimicrobial Resistance] |
---|
Grimshaw received an operating grant from as a co-Principal Investigator from [[Diabetes Action Canada]] for a study called "An implementation | Grimshaw received an operating grant from as a co-Principal Investigator from [[Diabetes Action Canada]] for a study called "An implementation |
science approach to increase attendance to retinopathy screening by people with [[diabetes]]."((Grimshaw, J. (2021). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20220508082748/https://covid19-sciencetable.ca/wp-content/uploads/2021/02/Declaration-of-Interest_Behavioural-Science-Working-Group_Jeremy-Grimshaw_20210513.pdf)) DAC is funded by [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Bayer]], [[pharmaceutical_companies:Merck]] and [[Sun Life Financial]].((//Strategic Partners.// Diabetes Action Canada - SPOR Network. Retrieved May 8, 2022, from https://archive.ph/upCkV)) | science approach to increase attendance to retinopathy screening by people with [[diabetes]]."((Grimshaw, J. (2021). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20220508082748/https://covid19-sciencetable.ca/wp-content/uploads/2021/02/Declaration-of-Interest_Behavioural-Science-Working-Group_Jeremy-Grimshaw_20210513.pdf)) DAC is funded by [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Bayer]], [[pharmaceutical_companies:Merck]] and [[Sun Life Financial]].((//Strategic Partners.// Diabetes Action Canada - SPOR Network. Retrieved May 8, 2022, from https://archive.ph/upCkV)) |
| |
| ==== Antimicrobial Resistance ==== |
| |
| Grimshaw has published research on [[antimicrobial resistance]] with funding by the [[Joint Programming Initiative on Antimicrobial Resistance Network]] (JPIARN).((Rzewuska, M., Charani, E., Clarkson, J. E., Davey, P. G., Duncan, E. M., Francis, J. J., Gillies, K., Kern, W. V., Lorencatto, F., Marwick, C. A., McEwen, J., Möhler, R., Morris, A. M., Ramsay, C. R., Rogers Van Katwyk, S., Skodvin, B., Smith, I., Suh, K. N., & Grimshaw, J. M. (2019). //Prioritizing research areas for antibiotic stewardship programmes in hospitals: a behavioural perspective consensus paper.// Clinical Microbiology and Infection, 25(2), 163–168. https://doi.org/10.1016/j.cmi.2018.08.020)) |
==== Awards and Recognition ==== | ==== Awards and Recognition ==== |
| |
Grimshaw was recognized as a [[Thomson Reuters]] Highly Cited Researcher in 2015, 2016 2017 and 2018.((//ICES scientists Peter Austin and Jeremy Grimshaw selected as 2016 Thomson Reuters Highly Cited Researchers.// (2016, November 18). ICES. https://archive.ph/ieRPL)) ((Grimshaw, J. M. (2019, June 3). //Curriculum Vitae.// McMaster University Health Forum. https://web.archive.org/web/20220509011301/https://www.mcmasterforum.org/docs/default-source/people-cv/grimshaw-cv.pdf?sfvrsn=53d154d5_3)) | Grimshaw was recognized as a [[Thomson Reuters]] Highly Cited Researcher in 2015, 2016 2017 and 2018.((//ICES scientists Peter Austin and Jeremy Grimshaw selected as 2016 Thomson Reuters Highly Cited Researchers.// (2016, November 18). ICES. https://archive.ph/ieRPL)) ((Grimshaw, J. M. (2019, June 3). //Curriculum Vitae.// McMaster University Health Forum. https://web.archive.org/web/20220509011301/https://www.mcmasterforum.org/docs/default-source/people-cv/grimshaw-cv.pdf?sfvrsn=53d154d5_3)) |